West Pharmaceutical Services Inc. (WST) Dividends

WST Price Forecast Based on Dividend Discount Model

A technique commonly used by dividend investors to value dividend-issuing stocks is the Dividend Discount Model (DDM), which seeks to determine a fair share price based on the dividend provided by the company relative to a number of other company-specific factors. As for WST, the DDM model generated by StockNews estimates a return of negative 94.42% in comparison to its current price. Some interesting points we thought investors may wish to consider regarding the dividend discount model forecast for West Pharmaceutical Services Inc are:

• In comparison to stocks we observe that provide shareholders with a dividend, West Pharmaceutical Services Inc's dividend yield of 0.17% is in the bottom 1.16%.
• Regarding its relative worth based on the dividend discount model, WST's provides a return of -94.42% based on the forecast of the dividend discount model we used relative to its current share price; this is a better return than 2.6% of all stocks we measured with our dividend discount model.
• Beta, which compares volatilty of an individual stock to that of the S&P 500, is lower for West Pharmaceutical Services Inc than it is for only 12.31% of other dividend issuers in the Healthcare sector.

WST Dividends vs. Peers